Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disorders

被引:5
作者
Bachanova, Veronika [1 ]
Nachman, Patrick H. [2 ]
机构
[1] Univ Minnesota, Div Hematol Oncol Transplantat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Div Nephrol & Hypertens, Minneapolis, MN USA
关键词
DISEASES;
D O I
10.1038/s41409-023-02084-3
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1175 / 1176
页数:2
相关论文
共 10 条
[1]   Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study [J].
Abramson, Jeremy S. ;
Palomba, M. Lia ;
Gordon, Leo I. ;
Lunning, Matthew A. ;
Wang, Michael ;
Arnason, Jon ;
Mehta, Amitkumar ;
Purev, Enkhtsetseg ;
Maloney, David G. ;
Andreadis, Charalambos ;
Sehgal, Alison ;
Solomon, Scott R. ;
Ghosh, Nilanjan ;
Albertson, Tina M. ;
Garcia, Jacob ;
Kostic, Ana ;
Mallaney, Mary ;
Ogasawara, Ken ;
Newhall, Kathryn ;
Kim, Yeonhee ;
Li, Daniel ;
Siddiqi, Tanya .
LANCET, 2020, 396 (10254) :839-852
[2]   Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells [J].
Bergmann, Christina ;
Mueller, Fabian ;
Distler, Joerg H. W. ;
Gyoerfi, Andrea-Hermina ;
Voelkl, Simon ;
Aigner, Michael ;
Kretschmann, Sascha ;
Reimann, Hannah ;
Harrer, Thomas ;
Bayerl, Nadine ;
Boeltz, Sebastian ;
Wirsching, Andreas ;
Taubmann, Jule ;
Roesler, Wolf ;
Spriewald, Bernd ;
Wacker, Jochen ;
Atzinger, Armin ;
Uder, Michael ;
Kuwert, Torsten ;
Mackensen, Andreas ;
Schett, Georg .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08) :1117-1120
[3]  
Crickx E, 2020, KIDNEY INT, V97, P885, DOI 10.1016/j.kint.2019.12.025
[4]  
Division of Population Health, NAT CTR CHRON DIS PR
[5]   Updated assessment of the prevalence, spectrum and case definition of autoimmune disease [J].
Hayter, Scott M. ;
Cook, Matthew C. .
AUTOIMMUNITY REVIEWS, 2012, 11 (10) :754-765
[6]   CD19 CAR T cell therapy effective for systemic lupus erythematosus [J].
Gelfand, J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (01) :4-4
[7]   Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma [J].
Neelapu, S. S. ;
Locke, F. L. ;
Bartlett, N. L. ;
Lekakis, L. J. ;
Miklos, D. B. ;
Jacobson, C. A. ;
Braunschweig, I. ;
Oluwole, O. O. ;
Siddiqi, T. ;
Lin, Y. ;
Timmerman, J. M. ;
Stiff, P. J. ;
Friedberg, J. W. ;
Flinn, I. W. ;
Goy, A. ;
Hill, B. T. ;
Smith, M. R. ;
Deol, A. ;
Farooq, U. ;
McSweeney, P. ;
Munoz, J. ;
Avivi, I. ;
Castro, J. E. ;
Westin, J. R. ;
Chavez, J. C. ;
Ghobadi, A. ;
Komanduri, K. V. ;
Levy, R. ;
Jacobsen, E. D. ;
Witzig, T. E. ;
Reagan, P. ;
Bot, A. ;
Rossi, J. ;
Navale, L. ;
Jiang, Y. ;
Aycock, J. ;
Elias, M. ;
Chang, D. ;
Wiezorek, J. ;
Go, W. Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26) :2531-2544
[8]   Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].
Schuster, Stephen J. ;
Bishop, Michael R. ;
Tam, Constantine S. ;
Waller, Edmund K. ;
Borchmann, Peter ;
McGuirk, Joseph P. ;
Jaeger, Ulrich ;
Jaglowski, Samantha ;
Andreadis, Charalambos ;
Westin, Jason R. ;
Fleury, Isabelle ;
Bachanova, Veronika ;
Foley, S. Ronan ;
Ho, P. Joy p ;
Mielke, Stephan ;
Magenau, John M. ;
Holte, Harald ;
Pantano, Serafino ;
Pacaud, Lida B. ;
Awasthi, Rakesh ;
Chu, Jufen ;
Anak, Ozlem ;
Salles, Gilles ;
Maziarz, Richard T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :45-56
[9]  
Wang J, CD19 TARGETED CHIMER
[10]   The risk of lymphoma development in autoimmune diseases - A meta-analysis [J].
Zintzaras, E ;
Voulgarelis, M ;
Moutsopoulos, HM .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (20) :2337-2344